SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Xceleron to Provide Otsuka Pharmaceutical Development & Commercialization, Inc. with META-ID™ Services to Obtain Critical Metabolism Information at Phase I.